Spesolimab: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Spesolimab. Educational only — not medical advice.

Labeled uses

SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg.

Source: FDA labeling via NIH DailyMed (set 41a481ee…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.